Coronavirus: Pakistan to conduct trials of Chinese COVID-19 vaccine

Published: Updated:
Enable Read mode
100% Font Size

Pakistan regulators have approved final-phase testing of a Chinese-made vaccine against the coronavirus, officials said Tuesday, in the country’s first ever clinical trial of its kind.

According to Pakistan’s National Institute of Health (NIH), regulators have approved the testing of a vaccine under development by CanSinoBio and the Beijing Institute of Biotechnology China.


Read the latest updates in our dedicated coronavirus section.

The medication is already undergoing Phase 3 trials - or large-scale testing on humans - in China, Russia, Chile and Argentina. Saudi Arabia will also take part, NIH said.

“This will be the first ever Phase 3 clinical trial for any vaccine in Pakistan,” the NIH said in a statement.

Pakistan’s inclusion in the trials would help it secure “preferential vaccine supply and pricing,” it added.

For all the latest headlines, follow our Google News channel online or via the app.

The trials will be conducted at several medical facilities across Pakistan, including the large Indus Hospital in Karachi.

“Hopefully we will come out with the vaccine within three to four months,” Abdul Bari, who heads the Indus Hospital, told AFP.

The coronavirus has claimed more than 6,000 lives in Pakistan but cases have been dropping for several weeks.

Read more:

Coronavirus: Pakistan allows all international flights to resume operations

Coronavirus: Scientists find lasting COVID-19 immunity in early studies

Top Content Trending